Osteoporosis

• Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies (PubMed)
• Cannabinoids and bone: Friend or foe? (PubMed)
• Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells (PubMed)
• Cannabinoids and the skeleton: From marijuana to reversal of bone loss (PubMed)
• The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy(PubMed)
• The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption (PubMed)
• Endocannabinoids and the regulation of bone metabolism (PubMed)
• Cannabinoid receptors and the regulation of bone mass (PubMed)
• Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health (PubMed)
• Peripheral cannabinoid receptor, CB2, regulates bone mass (PubMed)
• Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors (PubMed)
• Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis(PubMed)
• Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family (PubMed)